Last updated 54 days ago

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy

102 patients around the world
Available in Spain, Brazil, Argentina, United States
Theravance Biopharma
7Research sites
102Patients around the world
This study is for people with
Multiple System Atrophy
Requirements for the patient
From 30 Years
All Gender
Medical requirements
Sites
Hospital Británico de Buenos Aires - CABA
Hospital Británico de Buenos Aires - CABA
Recruiting
Perdriel 74, CABA, Buenos Aires
Consultorios Médicos Dr. Isaac Scherbovsky - Mendoza
Recruiting
José Federico Moreno 2760, Mendoza
Hospital General de Agudos J. M. Ramos Mejía - Buenos Aires, CABA
Urquiza 609, CABA, Buenos Aires
Hospital da Bahia - Centro Médico
Av. Prof. Magalhães Neto, 1541, ala A - Pituba, Salvador - BA, 41810-011
Hospital Das Clínicas Da Universidade Federal de Minas Gerais - UFMG
Av. Prof. Alfredo Balena, 110 2 floor - Room 216 - Santa Efigênia, Belo Horizonte - MG, 30130-100
Hospital de Clínicas de Porto Alegre - HCPA/UFRGS
Rua Ramiro Barcelos, 2350, Av. Protásio Alves, 211 - Santa Cecília, Porto Alegre - RS, 90035-903
Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul
Av. Ipiranga, 6690 - 4º andar - Partenon, Porto Alegre - RS, 90610-001, Brazil
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy